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know?
Laetitia Minodier1, Remi N. Charrel2, Pierre-Emmanuel Ceccaldi3, Sylvie van der Werf4,5, Thierry Blanchon6,7,
Thomas Hanslik7,8,9 and Alessandra Falchi1*
Abstract
This review provides for the first time an assessment of the current understanding about the occurrence and the
clinical significance of gastrointestinal (GI) symptoms in influenza patients, and their correlation with the presence
of human influenza viruses in stools of patients with confirmed influenza virus infection. Studies exploring how
human influenza viruses spread to the patient’s GI tract after a primary respiratory infection have been summarized.
We conducted a systematic search of published peer-reviewed literature up to June 2015 with regard to the above-
mentioned aspects, focusing on human influenza viruses (A(H1N1), A(H1N1)pdm09, A(H3N2), and B). Forty-four studies
were included in this systematic review and meta-analysis. The pooled prevalence of any digestive symptoms ranged
from 30.9 % (95 % CI, 9.8 to 57.5; I2 = 97.5 %) for A(H1N1)pdm09 to 2.8 % (95 % CI, 0.6 to 6.5; I2 = 75.4 %) for A(H1N1).
The pooled prevalence of influenza viruses in stool was 20.6 % (95 % CI, 8.9 to 35.5; I2 = 96.8 %), but their correlation
with GI symptoms has rarely been explored. The presence of viral RNA in stools because of haematogenous
dissemination to organs via infected lymphocytes is likely, but the potential to cause direct intestinal infection and
faecal–oral transmission warrants further investigation. This review highlights the gaps in our knowledge, and the
high degree of uncertainty about the prevalence and significance of GI symptoms in patients with influenza and
their correlation with viral RNA positivity in stool because of the high level of heterogeneity among studies.
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Background
The avian influenza A(H5N1) virus causes severe gastro-
intestinal (GI) symptoms and replicates in human intes-
tinal tissues [1, 2], but the potential of human influenza
viruses to cause direct intestinal injury during and/or
after a respiratory infection remains unclear.
Although the main route of human influenza virus
infection is respiratory, GI symptoms such as anorexia,
diarrhea, vomiting, and abdominal pain are common
manifestations [3–12], and may be a hallmark of severe
influenza [13–18]. Seasonal and pandemic influenza viral
RNA has been detected in stools of patients with con-
firmed influenza virus infection [19–27]. The influenza
virus has occasionally been isolated from stool samples
using cell culture [20, 22, 25].
The findings that faecal shedding of seasonal and
pandemic influenza viruses could occur in patients with
confirmed influenza raises the question of inadvertent
human- human transmission, despite emphasis on drop-
let transmission and precautions for contact with re-
spiratory secretions.
Our objective was to outline the current understand-
ing about the occurrence and clinical significance of GI
symptoms and human influenza viruses in the stools of
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patients with confirmed influenza virus infection. Know-
ledge from studies exploring how human influenza vi-
ruses spread to the patient’s GI tract after a primary
respiratory infection has been summarized.
This review describes for the first time the current
knowledge about the clinical significance and patho-
physiology of human influenza virus in faecal samples,
and, more importantly, highlights gaps in our knowledge
and areas where research is warranted.
Review
Search strategy
Using PubMed, we searched the MEDLINE database for
articles up to June 2015, without date restriction, using
the terms ‘human influenza virus’, ‘faeces’, ‘diarrhea’, ‘stom-
ach’, ‘faecal’, ‘intestinal cells’, ‘human intestinal’, ‘gut’, ‘viral
load’, and ‘detection’. The terms were used alone or in
combinations using Boolean operators. Only articles
published in English were included and the search cov-
ered all years available in the MEDLINE database.
Inclusion and exclusion criteria
We included studies according to the following eligibility
criteria: (1) observational studies comparing clinical fea-
tures between patients with influenza to estimate the
prevalence of GI symptoms by influenza virus type and/
or subtype; (2) case reports describing the occurrence of
GI symptoms in patients with influenza; (3) observa-
tional studies regarding the detection and/or isolation of
human influenza viruses in stools of patients with con-
firmed influenza by using upper and/or lower tract spec-
imens; and (4) experimental studies on intestinal binding
of human influenza viruses. The reference lists of all ar-
ticles were reviewed for additional sources of data. All
results were downloaded into an MS Word document
and we searched for duplicate citations. Two investiga-
tors screened all articles by title and by abstract. All arti-
cles meeting the criteria were screened for information
on study design, the time when the study was con-
ducted, sample size, patient information, clinical presen-
tation, nasopharyngeal and stool sample collection,
number of virologically confirmed cases in nasopharyn-
geal specimens, influenza RNA detection and viral
isolation from stool samples, method used for: viral de-
tection, confirmation, and isolation.
Article selection
Our initial search yielded 143 articles, and after screen-
ing titles, abstracts and full-texts with inclusion criteria,
16 publications were selected. Twenty-six additional
studies were retrieved by scanning the reference lists of
articles selected (Fig. 1).
Statistical analysis
We assessed the extent of the heterogeneity across stud-
ies of the prevalence of GI symptoms and the rate of de-
tection of influenza virus in stools among influenza
patients by using the Q statistic and I2 index [28]. These
tests assessed whether variation across component stud-
ies was due to true heterogeneity or by chance. Q is dis-
tributed as a χ2 statistic and I2 describes the percentage
of variation across studies that are due to heterogeneity
rather than chance, with values ranging from 0 to 100 %.
Data were pooled using either a random- or fixed-effects
model depending on the degree of heterogeneity; accept-
able heterogeneity was defined as I2 < 70 % [28]. In stud-
ies with a high level of heterogeneity (I2 > 70 %), a
random-effects model was used. Statistical analyses were
performed using MedCalc for Windows, version 12.5
(MedCalc Software, Ostend, Belgium).
What is the occurrence of gastrointestinal symptoms in
influenza patients?
We identified ten observational studies (six prospective
and four retrospective) describing and comparing the
occurrence of GI manifestation among patient mainly
using reference methods: RT-PCR [6–12] and/or cell
culture [4, 7] or in few studies, using serological tests
and MDCK culture [3] or PCR [5] to confirm human in-
fluenza virus infection (see Additional file 1). Among the
ten studies, four [3–5, 9] compared the clinical features
between patients with type A and/or B seasonal influ-
enza virus infection (see Additional file 1) and six com-
pared the clinical features between patients with
influenza A(H1N1)pdm09 virus and type A and/or B
seasonal influenza virus infections (see Additional file 1).
As detailed in additional file 1, of the ten studies se-
lected, four measured the occurrence of GI manifesta-
tions as ‘digestive symptoms’ or ‘gastrointestinal
symptoms or disorders’ [3, 4, 7, 8] and six reported
‘vomiting and/or nausea and/or diarrhea and/or abdom-
inal pain’ [5, 6, 9–12, 25]. Other symptoms such as
heartburn and anorexia are not addressed in the studies
included in this review.
Three of the ten studies reported that GI manifesta-
tions occurred more frequently in patients with con-
firmed influenza B virus infection than in those with
confirmed infection with human influenza A (A(H1N1),
A(H1N1)pdm09, and A(H3N2)) virus infection [3, 4, 6],
in contrast to reports of similar occurrences of these
symptoms among patients with seasonal influenza A or
B [5, 8, 10]. The occurrence of GI manifestations among
patients infected with influenza A(H1N1)pdm09 viruses
has been reported to be higher than that in patients in-
fected with seasonal influenza A viruses in three studies
[7, 11, 12]. GI symptoms were more frequent among
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Table 1 Heterogeneity of the meta-analysis on prevalence of gastrointestinal symptoms by symptoms category and virus (sub)-type
Meta-analysis Influenza virus (sub)-type Number of studies I2 Statistic[IC] Q Statistic (p-value)
Gastrointestinal symptoms A(H3N2) 4 96.9 % [94.4–98.3] 96.2 (p < 0.0001)
A(H1N1) 2 75.4 % [0.0–94.4] 4.1 (p = 0.0439)
A(H1N1)pdm09 3 97.5 % [95.1–98.7] 78.8 (p < 0.0001)
B 3 95.6 % [90.4–97.9] 45.5 (p < 0.0001)
Vomiting A(H3N2) 5 88.3 % [75.3–94.5] 34.2 (p < 0.0001)
A(H1N1)pdm09 2 75.4 % [0.0–94.4] 4.1 (p = 0.0439)
B 4 0 % [0–81.6] 2.5 (p = 0.4748)
Diarrhea A(H3N2) 4 86.9 % [68.4–94.6] 22.9 (p < 0.0001)
B 4 0 % [0.00–76.6] 1.7 (p = 0.6462)
Abdominal pain A(H3N2) 3 97.1 % [94.2–98.5] 68.5 (p < 0.0001)
B 2 0 % [0.00–0.00] 0.01 (p = 0.9005)
143 articles identified through 
PUBMED database 
143 titles of articles were screened
48 abstracts of articles were screened
95 articles were excluded
33 full-texts of articles were screened
15 articles were excluded
17 articles were excluded 
on the basis of 
inclusion/exclusion criteria 
16 full-texts of articles were selected
1 study included in 
qualitative synthesis of 
gastrointestinal symptoms 
10 studies included in 
qualitative synthesis of 
influenza virus detected in 
stool patients 
5 studies included in 
qualitative synthesis of 
pathogenesis
9 additional studies from 
reference lists
0 additional studies from 
reference lists
17 additional studies from 
reference lists
10 studies selected for the 
qualitative synthesis of 
gastrointestinal symptoms
10 studies selected for the 
qualitative synthesis of 
influenza viruses detected in 
stool from patients
22 studies selected for the 
qualitative synthesis of 
pathogenesis
Fig. 1 Flow diagram describing literature search and selection of studies
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Fig. 2 Forestplot of the meta-analysis on prevalence of gastrointestinal symptoms and pooled proportion of all types of gastrointestinal symptoms by
virus type and subtype
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patients infected with influenza A(H3N2) than among
those infected with influenza B viruses [9].
Because the findings of the ten studies are apparently
contradictory, we estimated the pooled prevalence of GI
symptoms (‘digestive symptoms, or gastrointestinal
symptoms or disorders’; ‘vomiting/nausea’; ‘diarrhea’ and
‘abdominal pain’) by a meta-analysis of the types and/or
subtypes of influenza virus infections (Table 1; Fig. 2).
As shown in Fig. 2, the results of the meta-analysis
assessing the pooled prevalence of any gastrointestinal
symptoms ranged from 30.9 % (95 % CI, 9.8 to 57.5;
I2 = 97.5 %) for influenza virus A(H1N1)pdm09 infec-
tion to 2.8 % (95 % CI, 0.6 to 6.6; I2 = 75.4 %) for in-
fluenza virus A(H1N1) infection. The most commonly
reported individual symptom was vomiting, with
pooled proportions ranging from 25.3 % (95 % CI,
22.2 to 28.6; I2 = 0 %) for influenza B virus infection
to 21.9 % (95 % CI, 15.2 to 29.4; I2 = 88.3 %) for in-
fluenza A(H3N2) virus infection.
As shown in Table 2, the results of the meta-analysis
assessing the pooled prevalence of any gastrointestinal
symptoms in the children population ranged from
46.3 % (95 % CI, 34.2 to 58.7; I2 = 96.7 %) for influenza
virus A(H1N1)pdm09 infection to 31.6 % (95 % CI, 36.3
to 43.1; I2 = 95.5 %) for influenza virus A(H3N2) infec-
tion. The most commonly reported individual symptom
was vomiting, with pooled proportions ranging from
37.5 % (95 % CI, 13.5 to 65.4; I2 = 89.7 %) for influenza
A(H3N2) virus to 25.6 % (95 % CI, 9.6 to 32.1; I2 =
60.9 %) for influenza B virus infection. Overall, hetero-
geneity across studies and/or wide confidence intervals
were observed for the pooled prevalence of all types of
GI symptoms analysed (Table 1, Fig. 2 and Table 2).
GI symptoms reported in case of severe influenza disease
Influenza A virus might induce severe GI complications.
Several studies reported GI symptoms such as acute
appendicitis, abdominal pain [17], and haemorrhagic gastri-
tis [14, 29, 30] in patients with severe influenza, especially
among children. The studies are described below.
Development of severe abdominal pain including appen-
dicitis [16] or haemorrhagic gastritis of varying severity
after a typical influenza-like illness was reported in children
with influenza virus infection [14, 16, 29, 30]. During the
A(H1N1)pdm09 pandemic clinicians reports noted an in-
creased incidence/severity of acute appendicitis [31].
Some influenza A(H1N1)pdm09 cases of appendicitis
have been reported in the literature [13, 31, 32] but
in all these cases it is difficult to prove whether the
A(H1N1)pdm09 virus infection caused the appendicitis or
whether it allowed the occurrence of bacterial secondary
infection. Cases of influenza A(H1N1)pdm09 virus infec-
tion mimicking acute abdominal pain in pregnancy [18]
and a case of haemorrhagic colitis after A(H3N2) influ-
enza virus infection in a 21-year-old man have been de-
scribed [33].
Two cases of sudden fatal influenza B virus infection
in young children complaining of abdominal pain and
vomiting without influenza-like symptoms have been re-
ported [17]. During the 2003–2004 influenza season,
153 deaths of children due to influenza (98 % influenza
A) were reported in the United States, of which 39 %
presented with vomiting, and 6 % with vomiting in the
absence of respiratory symptoms [15].
Overall these GI complications could have several aeti-
ologies as could be associated with oral administration of
oseltamivir for the treatment of influenza [34], to non-
steroidal anti-inflammatory use, to a direct viral effect or
to a bacterial secondary infection. Precise understanding
of intestinal complications as a consequence of an influ-
enza virus infection could be drawn from in situ
hybridization or PCR of infected tissues. The mechanisms
of severe GI complications during an influenza virus infec-
tion need to be elucidated and clinicians should be alerted
Table 2 Heterogeneity of the meta-analysis on prevalence of gastrointestinal symptoms by symptoms category and virus (sub)-type
for the children population
Meta-analysis Influenza virus (sub)-type Number of studies Prevalence I2 Statistic[IC] Q Statistic (p-value)
Gastrointestinal symptoms A(H3N2) 3 31.6 [36.33–43.15] 95.55 % [90.27–97.98] 45.1 (p < 0.0001)
A(H1N1) 1 /
A(H1N1)pdm09 2 46.3 [34.24–58.7] 96.75 % [47.69–96.64] 7.54(p = 0.0060)
B 1 /
Vomiting A(H3N2) 2 37.5 [13.54–65.36] 89.70 % [61.9–97.21] 9.7 (p = 0.0018)
A(H1N1)pdm09 1 /
B 2 25.6 [14.7–38.35] 19.27 % [0–0] 1.23(p = 0.2657)
Diarrhea A(H3N2) 2 19.6 [9.61–32.13] 60.97 % [0–90.93] 2.57 (p = 0.1095)
B 2 14.42 [7.48–23.52] 0 % [0.00–0.00] 0.06 (p = 0.8010)
Abdominal pain A(H3N2) 1 /
B 1 /
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to the possibility of an increased incidence/severity of GI
symptoms in patients with influenza.
Occurrence of influenza virus in the stools of children and
adults infected by influenza virus
There are ten reports of faecal viral RNA shedding after
analysis of: (i) hospitalized adult and/ or paediatric pa-
tients [19–25], or not hospitalized [26], (ii) adult patients
with diarrhea enrolled by general practitioners [35] and
(iii) patients of various ages in a retrospective analysis
on the aetiology of gastroenteritis performed using stool
specimens collected in a previous study [27]. The preva-
lence of influenza viral RNA in stool, detected by RT-
PCR in all included studies, ranged from 3 [22] to 71 %
in studies on children, from 7.2 % [27] to 47 % [23] in
studies on adults, and from 0.06 [26] to 44 % [25] in
studies on patients of various ages. Figure 3 shows the
results of the meta-analysis, which assessed the pooled
prevalence of influenza viral RNA in stools at 20.6 %
(95 % CI, 8.9 to 35.5; I2 = 96.8 %). Among the ten studies
reporting faecal viral RNA in stools, six of them have
conducted cell culture experiments viral RNA stool [20–
23, 25, 26], detected in all included studies by RT-PCR,
and three of them described one positive culture [20, 22,
25] (Fig. 3). Studies are detailed in additional file 2.viral
RNA Among the ten studies reporting faecal viral RNA
in stools, six have conducted cell culture and three have
described one positive culture (Fig. 3).
Pathogenesis
While influenza virus is likely to spread to the GI tract of
patients after a primary respiratory infection, the route of
dissemination remains unknown. Current knowledge
explains the detection of human influenza viruses in fae-
ces because of: (i) swallowing of influenza viruses from
the upper respiratory tract; (ii) remnants of infected sub-
mucosal intestinal antigen-presenting immune cells; and
(iii) virus replication in intestinal cells.
Swallowing of Influenza viruses from the upper
respiratory tract
A low pH environment, such as in the stomach, should
render most influenza viruses non-infectious by inducing
an irreversible conformational change of the viral haem-
agglutinin [36]. For this reason, influenza virus detection
in stools has generally been attributed to swallowed re-
spiratory secretions. However, in this case the acid labil-
ity of influenza viruses that destroys their infectivity
when passing through the stomach could also result in
viral RNA degradation. Therefore, in the hypothetical
scenario of swallowed influenza viruses from the upper
respiratory tract, the fact that influenza virus RNA and,
in some cases, infectious influenza virus was detected
and/or isolated from stools could indicate that the vi-
ruses were mixed with food and thus protected, or that
the gastric acidity was reduced as a consequence of
medical treatment [37], gastric disease [38], or mutations
conferring resistance to low pH [39, 40].
Remnants of infected submucosal intestinal antigen-
presenting immune cells
The faecal presence of influenza virus RNA may be related
to the detection of human influenza viral RNA in rem-
nants of infected intestinal antigen-presenting immune
cells. Influenza virus could bind intestinal cells such as DC-
SIGN+ CD68+ dendritic cells, which are localized in the
Fig. 3 Forestplot of meta-analysis on prevalence of influenza virus detection on stool samples, pooled prevalence and Q test and I2 test
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small and large intestine [41]. These intestinal DC-SIGN+
CD68+ cells act as antigen-presenting cells and participate
in the stimulation of immunity through T-cell activation
[42]. Antigen-presenting cells of various origins are suscep-
tible to infection by different influenza virus subtypes [43],
and may act as vehicles for extrapulmonary dissemination
of the virus [44]. The shedding of viable influenza virus in
stools in the absence of viraemia, suggests that the virus
does not disseminate to the GI tract haematogenously after
a primary respiratory tract infection [25, 45, 46].
Replication in intestinal cells
Shu et al. [47] found that receptors for influenza virus
were abundantly expressed on GI epithelial cells, which
are highly permissive of influenza virus replication in vitro
[48–50]. Human and avian influenza A viruses use differ-
ent receptors for cell entry [51]. Human-adapted influenza
A viruses preferentially bind to ‘humanlike’ sialic acid
(SA)–α2,6–galactose (Gal)-terminated saccharides (here-
after, SA-α2,6-Gal), whereas avian influenza A viruses pre-
fer receptors with ‘avian-like’ α2,3 linkages (hereafter, SA-
α2,3-Gal). Examination of human colonic samples indi-
cated that SA-α-2,6-Gal receptors are abundant on epithe-
lial cells of the GI tract, and SA-α-2,3-Gal receptors can
be found from the ileum to the rectum, with abundant ex-
pression of “avian-like” SA-α-2,3-Gal receptors in goblet
cells being found mostly in the large intestine [47].
Both types of SA receptors are expressed on the sur-
face of in vitro differentiated intestinal epithelial cells,
suggesting that both avian and human influenza vi-
ruses have the potential to infect and replicate in
human intestinal epithelial cells [47, 52]. Indeed, in-
fluenza A(H5N1) virus can directly target human gut
tissues [47]. Intestinal epithelial cells are also suscep-
tible to influenza A(H9N2) and A(H1N1)pdm09 vi-
ruses, and the infected cells become apoptotic with
elevated pro-inflammatory responses [53, 54].
A mouse model of respiratory influenza infection was
used to explore the hypothesis that respiratory influenza
virus can enter the GI tract and as a direct consequence of
its replication cause immune injury at this site [55]. Intra-
nasal inoculation of the mice with the influenza A/PR/8/
34 (PR8) strain led to injury within the intestine only
when the virus infected the respiratory tract with immune
injury occurring in the lung. In this model, no influenza
virus was detected in the small intestine, and direct infec-
tion of the intestine with influenza virus did not lead to in-
testinal immune injury. The lymphocytes derived from the
lung respiratory mucosa migrated into the intestinal mu-
cosa during respiratory influenza infection via the CCL-
25-CCR9 chemokine axis and destroyed the intestinal
microbiota homeostasis in the small intestine, and the
number of Escherichia coli (E.coli) in the intestinal tract
increased, perhaps leading to intestinal immune injury.
The hypothesis was Similar results were obtained when
infecting mice with three different subtypes of respiratory
influenza A viruses..
Influenza A virus significantly increases the adhesive
properties of mucosa-associated E. coli strains, inducing
the exposure of cellular receptors by intestinal cells [56].
The expression of these cellular receptors increased after
influenza virus infection of lung epithelial cells [57], and
influenza virus was shown to replicate efficiently in human
primary intestinal cells. These findings suggest that viral
infection of intestinal epithelial cells alters the glycosyla-
tion pattern of mucosal proteins and thereby increases
bacterial adhesiveness, increasing the number of E. coli,
thereby causing vomiting and diarrhea. These data suggest
an increased number of E. coli as a consequence of influ-
enza virus infection is the primary cause of intestinal in-
jury during influenza virus infection.
Conclusions
Although the human respiratory tract is the main target of
infection by influenza viruses, whether human influenza vi-
ruses are capable of local GI replication is unclear. This sys-
tematic review and meta-analysis shows that the present
knowledge on the clinical significance and pathophysiology
of human influenza viruses in the GI tract is scarce.
The meta-analysis of the occurrence of GI symptoms
among patients with influenza showed that they were in-
consistent. First, the degree of heterogeneity among the
ten studies included is so great that no specific GI symp-
toms can be described as typical for a patient with influ-
enza. Therefore no comparison of the occurrence of GI
symptoms among patients by types and/or subtypes of
influenza viruses was possible. Second, the 95 % CIs of
the prevalence rates were broad. The wide CIs could be
related to the small number of studies included and to
their small sample size. Moreover, the majority of studies
used different criteria to define GI symptoms (either
vomiting and/or diarrhea, abdominal pain or vomiting
and diarrhea, or GI symptoms not specified), different
laboratory methodologies (culture and/or RT-PCR, or
serological tests) and were mostly conducted in hospital-
ized patients.
Similarly, studies reporting human cases with viro-
logical evidence of influenza virus in stools should be
interpreted with caution because detection of viral RNA
without additional virological evidence, such as culture
or detection of anti-genomic RNA, does not necessary
imply infection. Overall, in these studies, few clinical
correlations were observed for viral RNA positivity and
GI symptoms, and culture positivity was rare.
The source of influenza viruses in faeces and how the
viruses pass through the GI tract is poorly understood.
On the one hand, the presence of viral RNA in stools
may be a consequence of haematogenous dissemination
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to organs through infected lymphocytes, while on the
other hand, influenza viruses were able to increase the
adhesive behaviour of mucosa-associated E. coli strains,
inducing the exposure of cellular receptors through rep-
lication in intestinal cells.
Several methodological issues warrant discussion. The
biggest challenge in extracting and compiling individual
study data for this review was the variation in definitions of
GI symptoms provided, the scarcity of data on the detec-
tion of RNA virus in stools, and the small sample size in
the studies, providing little power for comparison between
age classes or between types and subtypes of influenza vi-
ruses. Viral stool cultures from patients with respiratory in-
fections (with and without GI symptoms) are infrequently
required, and in the absence of standard methods for cul-
turing influenza virus from stools, the true occurrence of
infectious influenza virus in stools is unknown.
Additional studies of large prospective cohorts, examin-
ing GI symptoms in patients of all ages with severe and
mild influenza, with systematic detection and isolation of
influenza virus and other respiratory and enteric viruses
from the upper respiratory tract and in stools concomi-
tantly, and measuring influenza viral loads at respiratory
and non-respiratory sites may provide further insights into
the role of human influenza viruses in the GI tract. Under-
standing the viral shedding profiles of human influenza vi-
ruses might provide helpful information for understanding
virulence, cell tropism, and transmission dynamics, and for
designing management policies.
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